Physician profile
Andrew Taylor
NPI 1639157290
$587.95
in general payments reported to CMS, 2019-2025
13 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.94 · 2020: $82.37 · 2021: $6.41 · 2022: $63.83 · 2023: $48.18 · 2024: $138 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $124.02 | 2022-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Bard Peripheral Vascular, INC. | $68.94 | 2020 | |
| Organogenesis INC. | $57.67 | 2024-2025 | Affinity |
| Medtronic, INC. | $52.86 | 2022-2024 | Reliatack |
| Kci USA, INC. | $46.49 | 2022-2023 | 3m Coban, Prevena |
| Davol INC. | $44.82 | 2025 | Phasix Mesh |
| Cardinal Health 200 LLC | $37.34 | 2019 | |
| Integra Lifesciences Corporation | $32.61 | 2024-2025 | Integra, Tcc-Ez, Primatrix |
| Merck Sharp & Dohme LLC | $30.59 | 2024-2025 | Bridion |
| Solventum Corporation | $29.17 | 2024-2025 | V.A.C. Granufoam |
| W. L. Gore & Associates, INC. | $28.92 | 2019 | |
| Medtronic Vascular, INC. | $28.11 | 2019-2020 | |
| Reprise Biomedical, INC. | $6.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.